Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2004 Jul;80(945):388–393. doi: 10.1136/pgmj.2003.017236

An approach to drug induced delirium in the elderly

K Alagiakrishnan 1, C Wiens 1
PMCID: PMC1743055  PMID: 15254302

Abstract

Drugs have been associated with the development of delirium in the elderly. Successful treatment of delirium depends on identifying the reversible contributing factors, and drugs are the most common reversible cause of delirium. Anticholinergic medications, benzodiazepines, and narcotics in high doses are common causes of drug induced delirium. This article provides an approach for clinicians to prevent, recognise, and manage drug induced delirium. It also reviews the mechanisms for this condition, especially the neurotransmitter imbalances involving acetylcholine, dopamine, and gamma aminobutyric acid and discusses the age related changes that may contribute to altered pharmacological effects which have a role in delirium. Specific interventions for high risk elderly with the goal of preventing drug induced delirium are discussed.

Full Text

The Full Text of this article is available as a PDF (168.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boucher B. A., Witt W. O., Foster T. S. The postoperative adverse effects of inhalational anesthetics. Heart Lung. 1986 Jan;15(1):63–69. [PubMed] [Google Scholar]
  2. Brown A. S., Rosen J. Lithium-induced delirium with therapeutic serum lithium levels: a case report. J Geriatr Psychiatry Neurol. 1992 Jan-Mar;5(1):53–55. doi: 10.1177/002383099200500109. [DOI] [PubMed] [Google Scholar]
  3. Brown T. M. Drug-induced delirium. Semin Clin Neuropsychiatry. 2000 Apr;5(2):113–124. doi: 10.153/SCNP00500113. [DOI] [PubMed] [Google Scholar]
  4. Busto U. E., Sproule B. A., Knight K., Herrmann N. Use of prescription and nonprescription hypnotics in a Canadian elderly population. Can J Clin Pharmacol. 2001 Winter;8(4):213–221. [PubMed] [Google Scholar]
  5. Cepeda C., Levine M. S. Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum. Dev Neurosci. 1998;20(1):1–18. doi: 10.1159/000017294. [DOI] [PubMed] [Google Scholar]
  6. Chan D., Brennan N. J. Delirium: making the diagnosis, improving the prognosis. Geriatrics. 1999 Mar;54(3):28-30, 36, 39-42. [PubMed] [Google Scholar]
  7. Dimsdale J. E., Newton R. P., Joist T. Neuropsychological side effects of beta-blockers. Arch Intern Med. 1989 Mar;149(3):514–525. [PubMed] [Google Scholar]
  8. Elie M., Cole M. G., Primeau F. J., Bellavance F. Delirium risk factors in elderly hospitalized patients. J Gen Intern Med. 1998 Mar;13(3):204–212. doi: 10.1046/j.1525-1497.1998.00047.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Feinberg M. The problems of anticholinergic adverse effects in older patients. Drugs Aging. 1993 Jul-Aug;3(4):335–348. doi: 10.2165/00002512-199303040-00004. [DOI] [PubMed] [Google Scholar]
  10. Flacker J. M., Cummings V., Mach J. R., Jr, Bettin K., Kiely D. K., Wei J. The association of serum anticholinergic activity with delirium in elderly medical patients. Am J Geriatr Psychiatry. 1998 Winter;6(1):31–41. [PubMed] [Google Scholar]
  11. Foy A., O'Connell D., Henry D., Kelly J., Cocking S., Halliday J. Benzodiazepine use as a cause of cognitive impairment in elderly hospital inpatients. J Gerontol A Biol Sci Med Sci. 1995 Mar;50(2):M99–106. doi: 10.1093/gerona/50a.2.m99. [DOI] [PubMed] [Google Scholar]
  12. Furui T., Tanaka I., Iwata K. Alterations in Na(+)-K(+)-ATPase activity and beta-endorphin content in acute ischemic brain with and without naloxone treatment. J Neurosurg. 1990 Mar;72(3):458–462. doi: 10.3171/jns.1990.72.3.0458. [DOI] [PubMed] [Google Scholar]
  13. Han L., McCusker J., Cole M., Abrahamowicz M., Primeau F., Elie M. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med. 2001 Apr 23;161(8):1099–1105. doi: 10.1001/archinte.161.8.1099. [DOI] [PubMed] [Google Scholar]
  14. Hauber W. Involvement of basal ganglia transmitter systems in movement initiation. Prog Neurobiol. 1998 Dec;56(5):507–540. doi: 10.1016/s0301-0082(98)00041-0. [DOI] [PubMed] [Google Scholar]
  15. Inouye S. K., Charpentier P. A. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA. 1996 Mar 20;275(11):852–857. [PubMed] [Google Scholar]
  16. Inouye S. K., Charpentier P. A. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA. 1996 Mar 20;275(11):852–857. [PubMed] [Google Scholar]
  17. Inouye S. K. The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. Am J Med. 1994 Sep;97(3):278–288. doi: 10.1016/0002-9343(94)90011-6. [DOI] [PubMed] [Google Scholar]
  18. Kinirons M. T., Crome P. Clinical pharmacokinetic considerations in the elderly. An update. Clin Pharmacokinet. 1997 Oct;33(4):302–312. doi: 10.2165/00003088-199733040-00005. [DOI] [PubMed] [Google Scholar]
  19. Lip G. Y., Metcalfe M. J., Dunn F. G. Diagnosis and treatment of digoxin toxicity. Postgrad Med J. 1993 May;69(811):337–339. doi: 10.1136/pgmj.69.811.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Martin N. J., Stones M. J., Young J. E., Bédard M. Development of delirium: a prospective cohort study in a community hospital. Int Psychogeriatr. 2000 Mar;12(1):117–127. doi: 10.1017/s1041610200006244. [DOI] [PubMed] [Google Scholar]
  21. Meagher D. J. Delirium: optimising management. BMJ. 2001 Jan 20;322(7279):144–149. doi: 10.1136/bmj.322.7279.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Montamat S. C., Cusack B. J., Vestal R. E. Management of drug therapy in the elderly. N Engl J Med. 1989 Aug 3;321(5):303–309. doi: 10.1056/NEJM198908033210507. [DOI] [PubMed] [Google Scholar]
  23. Moore A. R., O'Keeffe S. T. Drug-induced cognitive impairment in the elderly. Drugs Aging. 1999 Jul;15(1):15–28. doi: 10.2165/00002512-199915010-00002. [DOI] [PubMed] [Google Scholar]
  24. Mühlberg W., Platt D. Age-dependent changes of the kidneys: pharmacological implications. Gerontology. 1999 Sep-Oct;45(5):243–253. doi: 10.1159/000022097. [DOI] [PubMed] [Google Scholar]
  25. Ota M., Mefford I. N., Naoi M., Linnoila M. Effects of morphine administration on catecholamine levels in rat brain; specific reduction of epinephrine concentration in hypothalamus. Neurosci Lett. 1991 Jan 2;121(1-2):129–132. doi: 10.1016/0304-3940(91)90666-h. [DOI] [PubMed] [Google Scholar]
  26. Parker B. M., Cusack B. J., Vestal R. E. Pharmacokinetic optimisation of drug therapy in elderly patients. Drugs Aging. 1995 Jul;7(1):10–18. doi: 10.2165/00002512-199507010-00002. [DOI] [PubMed] [Google Scholar]
  27. Richelson E. Treatment of acute depression. Psychiatr Clin North Am. 1993 Sep;16(3):461–478. [PubMed] [Google Scholar]
  28. Rudberg M. A., Pompei P., Foreman M. D., Ross R. E., Cassel C. K. The natural history of delirium in older hospitalized patients: a syndrome of heterogeneity. Age Ageing. 1997 May;26(3):169–174. doi: 10.1093/ageing/26.3.169. [DOI] [PubMed] [Google Scholar]
  29. Sipahimalani A., Masand P. S. Use of risperidone in delirium: case reports. Ann Clin Psychiatry. 1997 Jun;9(2):105–107. doi: 10.1023/a:1026209520113. [DOI] [PubMed] [Google Scholar]
  30. Skoog I., Wallin A., Fredman P., Hesse C., Aevarsson O., Karlsson I., Gottfries C. G., Blennow K. A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia. Neurology. 1998 Apr;50(4):966–971. doi: 10.1212/wnl.50.4.966. [DOI] [PubMed] [Google Scholar]
  31. Stone T. W. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev. 1993 Sep;45(3):309–379. [PubMed] [Google Scholar]
  32. Trzepacz P. T. The neuropathogenesis of delirium. A need to focus our research. Psychosomatics. 1994 Jul-Aug;35(4):374–391. doi: 10.1016/S0033-3182(94)71759-X. [DOI] [PubMed] [Google Scholar]
  33. Tune L. E., Egeli S. Acetylcholine and delirium. Dement Geriatr Cogn Disord. 1999 Sep-Oct;10(5):342–344. doi: 10.1159/000017167. [DOI] [PubMed] [Google Scholar]
  34. Unseld E., Ziegler G., Gemeinhardt A., Janssen U., Klotz U. Possible interaction of fluoroquinolones with the benzodiazepine-GABAA-receptor complex. Br J Clin Pharmacol. 1990 Jul;30(1):63–70. doi: 10.1111/j.1365-2125.1990.tb03744.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES